Email updates

Keep up to date with the latest news and content from BMC Pharmacology and Toxicology and BioMed Central.

Open Access Research article

No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trial

Robert Eggertsen*, Åke Andreasson and Lennart Andrén

BMC Pharmacology and Toxicology 2012, 13:10  doi:10.1186/2050-6511-13-10

Article Metrics

2563
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 61 accesses
  • Last 365 days: 604 accesses
  • All time: 2563 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information